
    
      To compare and evaluate the oral bioavailability of Asenapine Sublingual Tablets, 10 mg
      manufactured by AMNEAL PHARMACEUTICALS, USA with SAPHRISÂ® (asenapine) sublingual tablets, 10
      mg following a multiple-dose administration in adult human patients who are receiving a
      stable twice daily dose of asenapine maleate EQ 10 mg base.

      To monitor the safety and tolerability of a multiple doses of asenapine sublingual tablets 10
      mg in adult human patients who are receiving a stable twice daily dose of asenapine maleate
      EQ 10 mg base.
    
  